Form 4: NHC CEO Flatt Exercises Options, Adjusts Holdings
Insider Transaction Report
NATIONAL HEALTHCARE CORP CEO Stephen Flatt exercised stock options and subsequently sold shares to cover tax obligations, adjusting his direct beneficial ownership.
Summary
- Stephen Fowler Flatt, CEO and Director of National Healthcare Corp (NHC), engaged in transactions involving the company's common stock on March 2, 2026.
- Flatt exercised options to acquire 5,000 shares of common stock at an exercise price of $90.62 per share.
- Following this acquisition, his direct beneficial ownership of common stock increased to 67,237 shares.
- Concurrently, Flatt disposed of 3,585 shares of common stock at a price of $171.15 per share to satisfy tax obligations related to the option exercise.
- After these transactions, Flatt's direct beneficial ownership of common stock stands at 63,652 shares.
- The exercised options were granted on February 24, 2025, under the 2020 Omnibus Equity Incentive Plan.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a routine insider transaction, slightly positive due to the CEO exercising options, which generally signals confidence in the company's stock value, despite the subsequent sale for tax purposes.
Positives
- The exercise of 5,000 stock options by the CEO indicates confidence in the company's value.
- The exercise price of $90.62 is significantly lower than the disposition price of $171.15, suggesting a profitable transaction for the insider.
Negatives
- A portion of the acquired shares (3,585 shares) was immediately sold to cover tax obligations, resulting in a net decrease of 3,585 shares from the acquired amount.
Future Outlook
No forward-looking statements or guidance are provided in this Form 4 filing, which focuses solely on past insider transactions.
Industry Context
StockSavvy.ai notes that insider transactions like option exercises and subsequent tax-related sales are common occurrences in the healthcare industry, reflecting executive compensation structures tied to equity performance. This specific filing does not provide broader industry insights.
Comparison to Industry Standards
- This Form 4 filing details a standard insider transaction involving stock option exercise and subsequent share withholding for tax purposes.
- Such transactions are typical across publicly traded companies, including those in the healthcare sector, and align with common executive compensation practices.
- No specific comparable companies or projects are mentioned in the filing to allow for a detailed comparative assessment of results.
Related Party Transactions
- The exercise of stock options by Stephen Fowler Flatt, a CEO and Director, is a related party transaction as it involves an executive and the company.
- The subsequent disposition of shares to cover tax obligations is also part of this related party transaction.
Stakeholder Impact
- Shareholders: The exercise of options and subsequent sale for taxes by a key executive can be viewed as a normal part of compensation, but the net reduction in direct beneficial ownership might be scrutinized by some investors.
- Employees: No direct impact on employees is indicated.
- Customers: No direct impact on customers is indicated.
- Suppliers: No direct impact on suppliers is indicated.
- Creditors: No direct impact on creditors is indicated.
Key Dates
| Date | Description |
|---|---|
| 2024-03-08 | Date exercisable for 6,147 options at $53.94, expiring 2028-03-08. |
| 2025-02-24 | Grant date for the 5,000 stock options exercised on 2026-03-02. |
| 2025-03-05 | Date exercisable for 10,000 options at $94.1, expiring 2029-03-05. |
| 2026-02-28 | Date exercisable for 13,000 remaining options at $90.62, expiring 2030-02-28. |
| 2026-03-02 | Date of option exercise and share disposition transactions. |
| 2026-03-03 | Signature date of the reporting person. |
| 2027-02-23 | Date exercisable for 20,000 options at $157.13, expiring 2031-02-23. |
Recommendation
holdThis Form 4 filing details a routine insider transaction where the CEO exercised stock options and sold a portion to cover tax liabilities. While the exercise indicates a belief in the company's value, the transaction itself does not provide new fundamental information about the company's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as this filing alone does not present a compelling reason to buy or sell.
Keywords
NATIONAL HEALTHCARE CORP, NHC, Stephen Fowler Flatt, CEO, Director, Form 4, Insider Trading, Stock Options, Equity Incentive Plan, Beneficial Ownership, Share Transaction, Tax Obligations
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.